Back to results

CompletedPhase 2

A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer

NCT00371254

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Ucsf-Comprehensive Cancer Center

San Francisco, California, United States

+9 additional locations

View on ClinicalTrials.gov

A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer — TrialFind